Medicines Co.’s Bivalirudin Heart Drug Recommended by NICE

The Medicines Co announced that the National Institute for Health and Clinical Excellence (NICE) has recommended Bivalirudin for treatment of adults with ST-segment-elevation myocardial infarction (STEMI).
RTTNews